Adma Biologics Inc

Most Recent

  • uploads///Graph
    Company & Industry Overviews

    ADMA Biologics: Wall Street Projects Robust Revenue Growth

    ADMA Biologics (ADMA) has two commercialized assets in its portfolio, Nabi-HB and BIVIGAM, which it added through the acquisition of assets from Biotest Pharmaceuticals Corporation.

    By Margaret Patrick
  • uploads///medicine _
    Company & Industry Overviews

    Why ADMA Biologics Stock Soared Yesterday

    Yesterday, ADMA Biologics (ADMA) closed at $5.06, which is about 24.32% higher than its previous closing price.

    By Margaret Patrick
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.